open access

Vol 86, No 1 (2015)
ARTICLES
Get Citation

Fetal therapy – evaluation of intrauterine therapy in congenital cystic adenomatoid malformation of the lung (CCAM)

Krzysztof Szaflik, Magdalena Litwińska, Przemysław Oszukowski, Anna Piaseczna-Piotrowska, Ewelina Litwińska, Waldemar Krzeszowski, Ewa Gulczyńska, Iwona Maroszyńska, Katarzyna Janiak
DOI: 10.17772/gp/1892
·
Ginekol Pol 2015;86(1).

open access

Vol 86, No 1 (2015)
ARTICLES

Abstract

Objectives: The aim of the study was to evaluate the efficiency of intrauterine treatment of large cysts in fetal lungs using thoracoamniotic shunts. Material and methods: Our observational retrospective study was carried out on a series of 8 fetuses who underwent thoracoamniotic shunting after sonographic statement of large macrocystic lesions in the lungs at the Department of Gynecology, Fertility and Therapy of the Fetus, Polish Mother’s Research Institute, between 2009-2014. Results: Mean gestational age at shunt insertion was 26.6 (range 18-33) weeks. Marked mediastinal shift in theechocardiographic examination was observed in all of the investigated cases. Five fetuses had polyhydramion, with 4 hydropic cases. Out of the remaining 4 fetuses without impaired cardiac function, 3 had very large lesions at initial presentation and 1 had a lesion that was rapidly increasing in size. Shunt insertion was successful in all cases. Only one patient went into premature labor (at 36 weeks of gestation). Mean gestational age at delivery was 38.2 weeks. Cesarean section was necessary in the half of the patients due to obstetric complications. All newborns underwent resection of the lesions. Three of them were operated in the first month after birth. The rest of the operations were postponed. Prenatal diagnosis of congenital cystic adenomatoid malformations was confirmed by pathologists in all cases. Conclusion: Intrauterine therapy of macrocystic lesions in fetal lungs enables to achieve good perinatal outcome. It needs to be considered in every case of a fetus with developing impaired cardiac function.

Abstract

Objectives: The aim of the study was to evaluate the efficiency of intrauterine treatment of large cysts in fetal lungs using thoracoamniotic shunts. Material and methods: Our observational retrospective study was carried out on a series of 8 fetuses who underwent thoracoamniotic shunting after sonographic statement of large macrocystic lesions in the lungs at the Department of Gynecology, Fertility and Therapy of the Fetus, Polish Mother’s Research Institute, between 2009-2014. Results: Mean gestational age at shunt insertion was 26.6 (range 18-33) weeks. Marked mediastinal shift in theechocardiographic examination was observed in all of the investigated cases. Five fetuses had polyhydramion, with 4 hydropic cases. Out of the remaining 4 fetuses without impaired cardiac function, 3 had very large lesions at initial presentation and 1 had a lesion that was rapidly increasing in size. Shunt insertion was successful in all cases. Only one patient went into premature labor (at 36 weeks of gestation). Mean gestational age at delivery was 38.2 weeks. Cesarean section was necessary in the half of the patients due to obstetric complications. All newborns underwent resection of the lesions. Three of them were operated in the first month after birth. The rest of the operations were postponed. Prenatal diagnosis of congenital cystic adenomatoid malformations was confirmed by pathologists in all cases. Conclusion: Intrauterine therapy of macrocystic lesions in fetal lungs enables to achieve good perinatal outcome. It needs to be considered in every case of a fetus with developing impaired cardiac function.
Get Citation

Keywords

macrocystic type CCAM / intrauterine therapy / thoracoamniotic shunt

About this article
Title

Fetal therapy – evaluation of intrauterine therapy in congenital cystic adenomatoid malformation of the lung (CCAM)

Journal

Ginekologia Polska

Issue

Vol 86, No 1 (2015)

DOI

10.17772/gp/1892

Bibliographic record

Ginekol Pol 2015;86(1).

Keywords

macrocystic type CCAM / intrauterine therapy / thoracoamniotic shunt

Authors

Krzysztof Szaflik
Magdalena Litwińska
Przemysław Oszukowski
Anna Piaseczna-Piotrowska
Ewelina Litwińska
Waldemar Krzeszowski
Ewa Gulczyńska
Iwona Maroszyńska
Katarzyna Janiak

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl